Skip to content

Development of Walk Assist Device to Improve Community Ambulation

Randomized Control Trial Comparing Walking Task Specific Training With Stride Management Assist (SMA) Device vs.Functional Task Specific Training on Functional Walking Ability in Outpatient Stroke Rehabilitation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01994395
Enrollment
53
Registered
2013-11-25
Start date
2013-10-31
Completion date
2020-02-29
Last updated
2020-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Gait, Stride Management Assist, Mild-moderate Stroke, post 30 days or longer

Brief summary

Hypothesis/Specific Aims: The purpose of this study is to determine the effect of training with the Stride Management Assist (SMA) device vs. Impairment based physical therapy (IPT) on descending corticospinal drive to the lower limb muscles in patients post stroke. The investigators hypothesize that long-term SMA use would strengthen the connections between the motor areas of the brain and the lower limbs. Specifically, individuals in the SMA group will show higher corticospinal excitability of the lower limb muscles compared to those in the IPT group.

Detailed description

This is a randomized control trial comparing task specific training with the Stride Management Assist (SMA) device verses an impairment based physical therapy (IPT) approach on functional walking ability in outpatient stroke rehabilitation. Participants between the ages of 18-80 and who are 30 days or greater post stroke will be included. This SMA robotic device assists hip flexion and extension, for each side independently. It is controlled through software run on a tablet. The device weighs 2.8 kgs, and has 2 brushless direct current motors running on a rechargeable lithium ion battery. It comes in 3 sizes (small, medium and large). It is worn around like a belt with the motors near the hips and straps on the thighs. The SMA device allows users to increase their stride length by providing assist with the motors in flexion and extension. This device is 1) simple to use in the clinical setting; 2) easily adjustable to alter according to the requirements of each subject; and, 3) can quantify the amount of assistance required to facilitate walking patterns. Participants post stroke 30 days or greater will be recruited from inpatient, day rehabilitation and outpatient clinics. Participants will be scheduled for 18 Sessions of outpatient physical therapy plus 3 sessions of testing. The amount of sessions provided will be dependent upon compatibility with the device and ability to tolerate the device. A participant will continue with each session of the study as deemed appropriate by research staff. * A. Phase I. (session 0): After consenting, subjects will undergo a physical evaluation and screening exam by a licensed physical therapist. If they meet study criteria, they will be randomly placed into either the SMA group or the IPT group using a random number generator and they will be entered into the study. Once they are enrolled, baseline outcome measures will be assessed by a blinded research physical therapist. * B. Phase II. (sessions 1-9): * Stride Management Assist Group: Treatment consists of 30 minutes high intensity gait training with device, 15 minutes functional mobility with device. * Impairment Based Physical Therapy Group: Treatment will be divided into: 15 min balance training, 15 minutes functional mobility (transfers, strength or flexibility training) and 15 min high intensity gait training * C. Phase III. (session 10): Mid treatment assessment. Outcome measures will be assessed by a blinded research physical therapist. * D. Phase II. (sessions 11-19): * Stride Management Assist Group: Treatment consists of 30 minutes high intensity gait training with device, 15 minutes functional mobility with device. * Impairment Based Physical Therapy Group: Treatment will be divided into: 15 min balance training, 15 minutes functional mobility (transfers, strength or flexibility training) and 15 min high intensity gait training * E. Phase IV. (session 20): Post Testing. Outcome measures will be assessed by a blinded research physical therapist. All testing and training sessions will be under the supervision of a licensed physical therapist. All subjects will be permitted to stop physical activity or rest at any time during the study. Adverse events will be recorded. The investigators anticipate this study will help determine if the Stride Management Assist is a practical option to better strengthen the connections between the brain and the lower limbs. The investigators do not foresee any potential pitfalls.

Interventions

DEVICEThe Stride Management Assist (SMA) System

Participants will participate in 18 sessions of outpatient physical therapy + 3 sessions of testing for up to 8 weeks. Assessment (strength, flexibility, balance, sensation, endurance, transfers, gait. Treatment consists of 30 minutes high intensity gait training with device, 15 minutes functional mobility with device.

OTHERImpairment based therapy

Participants participate in 18 weeks of outpatient physical therapy + 3 assessment sessions. Assessment (strength, flexibility, balance, sensation, endurance, transfers, gait). Treatment will be divided into: 15 min balance training, 15 minutes functional mobility (transfers, strength or flexibility training) and 15 min high intensity gait training

Sponsors

Honda
CollaboratorUNKNOWN
Shirley Ryan AbilityLab
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

A blinded research physical therapist will test the outcome measure at baseline, Mid Testing after Session 9 , at Post Testing after Session 18 and at 3 month follow up testing after Session 18.

Intervention model description

The SMA group (task specific training) will be trained to simulate the demands of overground walking. The impairment based group will match the SMA group in intensity but will be focused on balance and other functional goals rather than explicitly on walking. The rationale of this study is to assess task specific training with SMA vs. impairment based training. To this end, we will use the Stride Management Assist device by Honda Corporation and compare it to impairment based physical therapy in outpatient sessions.

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* ≥ 30-days post stroke * Initial gait speed of \> 0.4 m/s and \< 0.8 m/s * Adequate cognitive function (MMSE score \>17) * Subject is willing to be randomized to the control group or the treatment group. * Ability to sit unsupported for 30 seconds * Ability to walk at least 10m with maximum 1 person assist, * Ability to follow a three-step command * Physician approval for patient participation * Living in the community post-stroke with ability to travel to the intervention site to participate in the outpatient program and able to perform the home exercise program in the residential facility. * Willing to carry wireless body sensors through the period of the study and to follow-up time period, post inpatient stroke, cardiac, pulmonary, or any other lower extremity physical rehabilitation * ≥ 90 days post major orthopedic surgery (i.e. hip, knee, and/or ankle joint replacement) * ≥ 6 months post coronary artery bypass grafting (CABG) or cardiac valve procedure * Able and willing to give written consent and comply with study procedures, including follow-up visits * Cannot not be participating in any other structured outpatient or home health physical therapy program

Exclusion criteria

* Serious cardiac conditions (hospitalization for myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living) * Severe arthritis or orthopedic problems that limit passive ranges of motion (ROM) of lower extremity (knee flexion contracture of \> 10°, knee flexion ROM \< 90°, hip flexion contracture \> 25°, and ankle plantar flexion contracture \> 15 * Serious medical conditions including myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living, Severe hypertension, severe weight bearing pain, life expectancy less than one year * Preexisting neurological disorders such as Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), dementia * History of major head trauma, Lower extremity amputation, Non-healing ulcers of a lower extremity, Renal dialysis or end stage liver disease, Legal blindness or severe visual impairment, a history of significant psychiatric illness * History of unexplained, recurring headaches, epilepsy/seizures/skull fractures or skull deficits * Medications that lower seizure threshold * History of concussion in last 6 months * Subject is pregnant, nursing or planning a pregnancy * Inability to travel 3 times per week for outpatient training programs * Participating in another clinical trial that, according to the Principal Investigator, is likely to affect study outcome or confound results

Design outcomes

Primary

MeasureTime frameDescription
Change in 10 Meter Walk Test From Baseline in Gait SpeedBaseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)Measure of self selected and fast walking speeds by measuring the time it takes an individual to walk 10 meters. The test is performed using a flying start, patient walks 10 meters (33 ft) and the time is measured when the leading foot crosses the start line and the finish line. The instructions are: Please walk this distance at your normal pace when I say go. and repeated Please walk this distance as fast as you can safely when I say go.

Secondary

MeasureTime frameDescription
Numeric Pain Rating Scale (NPRS)Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)The NPRS is an 11-point scale from 0-10 where patients verbally select a value that is most in line with the intensity of pain that they have experienced in the last 24 hours from 0 (no pain) to 10 (the most intense pain imaginable).
Stroke Specific Quality of Life Scale (SS-QOL)Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)A 49 item assessment grouped into 12 domains of health-related quality of life in stroke survivors; including areas of mobility, energy, upper extremity function, work and productivity, mood, self-care, social roles, family roles, vision, language, thinking, personality. Each individual domain consists of 3 to 10 items that are averaged to generate an overall score, each item is rated on a 5- point Likert scale, with a minimum value of 1 (meaning the worst outcome) and a maximum value of 5 (meaning the best outcome). Domains scores (non-weighted average of item scores) and a summary score (non-weighted average of all 12 domain scores) are computed. Summary scores range from 49-245, with higher scores indicating better functioning.
The Modified Falls Efficacy Scale (mFES)Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)14 item questionnaire assessing individuals' confidence in their ability to perform tasks without falling. Individuals rate their confidence from 0 (not confident at all) to 100 (completely confident).
Activities-Specific Balance Confidence Scale (ABC)Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)ABC is a 16-item self-report measure in which patients rate their balance confidence in performing various ambulatory activities without falling. Items are rated on a scale ranging from 0-100, with zero representing no confidence and 100 representing complete confidence.
Participants Receiving Transcranial Magnetic Stimulation (TMS)Session 0 (initial visit);Session 20 (between 6-8 weeks)To compare the effect of training on the connections between the brain and leg muscles (descending corticomotor drive) using a non-invasive brain stimulation called transcranial magnetic stimulation (TMS). TMS is a safe, non-invasive, painless method of brain stimulation that has been widely used to study the physiology of the representations of muscles in the motor cortex in healthy and neurologically disordered individuals13. Very short duration (\< 1 ms) magnetic pulses are applied via an insulated wire coil placed on the intact scalp overlaying the motor cortical area projecting to a target muscle. Each pulse induces a motor evoked potential (MEP) in a target muscle that can be readily monitored by recording Electromyogram (EMG) from that muscle. A figure-of-eight or double cone coil is typically used to deliver focal magnetic pulses to a number of scalp sites over the cortical area representing a muscle of interest.
Change in 6 Minute Walk Test From Baseline in Distance (6MWT)Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)The 6 Minute Walk Test (6MWT) is a test of endurance, by measuring the distance a subject can walk indoors on a flat, hard surface in a period of 6 minutes, using assistive devices, as necessary.The distance is measured with a measuring wheel. The instructions are Walk covering as much ground as you can in 6 min. You can stop to sit or stand if needed, but time will keep running. The change in the distance walked in the 6-minute walk can be used to evaluate the efficacy of an exercise-training program or to trace the natural history of change in exercise capacity over time. The 6MWT is measured in meters.
Berg Balance Scale (BBS)Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)The BBS is a 14-item objective measure designed to assess static balance and fall risk in adult populations and is a well-accepted measure in the stroke literature. The functional activities that are assessed include sitting and standing balance during transfers, altered base of support, reaching, turning, eyes open and closed. Each item is scored from 0 to 4 points. The maximum score is 56 points. A score from 0 to 20 represents balance impairment, 21 to 40 represents acceptable balance, and 41-56 represents good balance. The minimal detectable change score for individuals with acute stroke is 6.9 points16 and 4.66 points in chronic stroke17.
Patient Health Questionnaire-9 (PHQ-9)Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)PHQ-9 is a 9-item self-report questionnaire designed to diagnose both the presence of depressive symptoms as well as to characterize the severity of depression. A single question rates how difficult problems have made it to do work, take care of things at home or get along with other people using a 4 level scale (not difficult at all to extremely difficult). Each item is scored from 0-3; total scores may be 0-27, with higher scores representing increased severity of depression.

Countries

United States

Participant flow

Participants by arm

ArmCount
Stride Management Assist (SMA) System
Participants will be randomized into either the SMA group or impairment based (IPT) group. The Stride Management Assist (SMA) System: Participants will participate in 18 sessions of outpatient physical therapy + 3 sessions of testing for up to 8 weeks. Assessment (strength, flexibility, balance, sensation, endurance, transfers, gait. Treatment consists of 30 minutes high intensity gait training with device, 15 minutes functional mobility with device.
26
Impairment Based Therapy
Impairment based therapy will include traditional functional mobility training physical therapy. Impairment based therapy: Participants participate in 18 weeks of outpatient physical therapy + 3 assessment sessions. Assessment (strength, flexibility, balance, sensation, endurance, transfers, gait). Treatment will be divided into: 15 min balance training, 15 minutes functional mobility (transfers, strength or flexibility training) and 15 min high intensity gait training
27
Total53

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject12

Baseline characteristics

CharacteristicTotalImpairment Based TherapyStride Management Assist (SMA) System
10 Meter Walk Test0.68 meters per second
STANDARD_DEVIATION 0.1
0.65 meters per second
STANDARD_DEVIATION 0.1
0.7 meters per second
STANDARD_DEVIATION 0.1
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
17 Participants11 Participants6 Participants
Age, Categorical
Between 18 and 65 years
36 Participants16 Participants20 Participants
Age, Continuous61 years
STANDARD_DEVIATION 11.5
62 years
STANDARD_DEVIATION 13
60 years
STANDARD_DEVIATION 10
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
50 participants25 participants25 participants
Sex: Female, Male
Female
17 Participants9 Participants8 Participants
Sex: Female, Male
Male
33 Participants16 Participants17 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 25
other
Total, other adverse events
0 / 250 / 25
serious
Total, serious adverse events
0 / 250 / 25

Outcome results

Primary

Change in 10 Meter Walk Test From Baseline in Gait Speed

Measure of self selected and fast walking speeds by measuring the time it takes an individual to walk 10 meters. The test is performed using a flying start, patient walks 10 meters (33 ft) and the time is measured when the leading foot crosses the start line and the finish line. The instructions are: Please walk this distance at your normal pace when I say go. and repeated Please walk this distance as fast as you can safely when I say go.

Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)

Population: One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.

ArmMeasureGroupValue (MEAN)Dispersion
Stride Management Assist (SMA) SystemChange in 10 Meter Walk Test From Baseline in Gait SpeedBaseline Assessment0.7051 meters per secondStandard Deviation 0.122677
Stride Management Assist (SMA) SystemChange in 10 Meter Walk Test From Baseline in Gait SpeedMid Training Assessment0.8544 meters per secondStandard Deviation 0.202805061
Stride Management Assist (SMA) SystemChange in 10 Meter Walk Test From Baseline in Gait SpeedPost Training Assessment0.9566 meters per secondStandard Deviation 0.20176847
Stride Management Assist (SMA) SystemChange in 10 Meter Walk Test From Baseline in Gait Speed3 Month Post Training Assessment0.9439 meters per secondStandard Deviation 0.226535699
Impairment Based TherapyChange in 10 Meter Walk Test From Baseline in Gait Speed3 Month Post Training Assessment0.8085 meters per secondStandard Deviation 0.169381067
Impairment Based TherapyChange in 10 Meter Walk Test From Baseline in Gait SpeedBaseline Assessment0.6606 meters per secondStandard Deviation 0.12067815
Impairment Based TherapyChange in 10 Meter Walk Test From Baseline in Gait SpeedPost Training Assessment0.8376 meters per secondStandard Deviation 0.191048354
Impairment Based TherapyChange in 10 Meter Walk Test From Baseline in Gait SpeedMid Training Assessment0.7547 meters per secondStandard Deviation 0.16119851
Secondary

Activities-Specific Balance Confidence Scale (ABC)

ABC is a 16-item self-report measure in which patients rate their balance confidence in performing various ambulatory activities without falling. Items are rated on a scale ranging from 0-100, with zero representing no confidence and 100 representing complete confidence.

Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)

Population: One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.

ArmMeasureGroupValue (MEAN)Dispersion
Stride Management Assist (SMA) SystemActivities-Specific Balance Confidence Scale (ABC)Pre Training Assessment66.7625 units on a scaleStandard Deviation 18.00944
Stride Management Assist (SMA) SystemActivities-Specific Balance Confidence Scale (ABC)Mid Training Assessment73.2067 units on a scaleStandard Deviation 15.44828
Stride Management Assist (SMA) SystemActivities-Specific Balance Confidence Scale (ABC)Post Training Assessment79.1630 units on a scaleStandard Deviation 13.30643987
Stride Management Assist (SMA) SystemActivities-Specific Balance Confidence Scale (ABC)3 Month Post Training Assessment81.6292 units on a scaleStandard Deviation 11.41238
Impairment Based TherapyActivities-Specific Balance Confidence Scale (ABC)3 Month Post Training Assessment78.3749 units on a scaleStandard Deviation 13.50986798
Impairment Based TherapyActivities-Specific Balance Confidence Scale (ABC)Pre Training Assessment67.6472 units on a scaleStandard Deviation 17.7136527
Impairment Based TherapyActivities-Specific Balance Confidence Scale (ABC)Post Training Assessment77.99 units on a scaleStandard Deviation 13.3571932
Impairment Based TherapyActivities-Specific Balance Confidence Scale (ABC)Mid Training Assessment70.4443 units on a scaleStandard Deviation 17.4234304
Secondary

Berg Balance Scale (BBS)

The BBS is a 14-item objective measure designed to assess static balance and fall risk in adult populations and is a well-accepted measure in the stroke literature. The functional activities that are assessed include sitting and standing balance during transfers, altered base of support, reaching, turning, eyes open and closed. Each item is scored from 0 to 4 points. The maximum score is 56 points. A score from 0 to 20 represents balance impairment, 21 to 40 represents acceptable balance, and 41-56 represents good balance. The minimal detectable change score for individuals with acute stroke is 6.9 points16 and 4.66 points in chronic stroke17.

Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)

Population: One subject dropped out at baseline screening, prior to assignment to any group. One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.

ArmMeasureGroupValue (MEAN)Dispersion
Stride Management Assist (SMA) SystemBerg Balance Scale (BBS)Pre Training Assessment44 units on a scale, each item scored 0-4Standard Deviation 6
Stride Management Assist (SMA) SystemBerg Balance Scale (BBS)Mid Training Assessment46 units on a scale, each item scored 0-4Standard Deviation 6
Stride Management Assist (SMA) SystemBerg Balance Scale (BBS)Post Training Assessment48 units on a scale, each item scored 0-4Standard Deviation 4
Stride Management Assist (SMA) SystemBerg Balance Scale (BBS)3 Month Post Training Assessment48 units on a scale, each item scored 0-4Standard Deviation 4
Impairment Based TherapyBerg Balance Scale (BBS)3 Month Post Training Assessment48 units on a scale, each item scored 0-4Standard Deviation 3
Impairment Based TherapyBerg Balance Scale (BBS)Pre Training Assessment44 units on a scale, each item scored 0-4Standard Deviation 4
Impairment Based TherapyBerg Balance Scale (BBS)Post Training Assessment48 units on a scale, each item scored 0-4Standard Deviation 3
Impairment Based TherapyBerg Balance Scale (BBS)Mid Training Assessment46 units on a scale, each item scored 0-4Standard Deviation 4
Secondary

Change in 6 Minute Walk Test From Baseline in Distance (6MWT)

The 6 Minute Walk Test (6MWT) is a test of endurance, by measuring the distance a subject can walk indoors on a flat, hard surface in a period of 6 minutes, using assistive devices, as necessary.The distance is measured with a measuring wheel. The instructions are Walk covering as much ground as you can in 6 min. You can stop to sit or stand if needed, but time will keep running. The change in the distance walked in the 6-minute walk can be used to evaluate the efficacy of an exercise-training program or to trace the natural history of change in exercise capacity over time. The 6MWT is measured in meters.

Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)

Population: One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.

ArmMeasureGroupValue (MEAN)Dispersion
Stride Management Assist (SMA) SystemChange in 6 Minute Walk Test From Baseline in Distance (6MWT)Pre Training Assessment874.6067 units on a scaleStandard Deviation 220.4362
Stride Management Assist (SMA) SystemChange in 6 Minute Walk Test From Baseline in Distance (6MWT)Mid Treatment Assessment1140.5040 units on a scaleStandard Deviation 364.1122684
Stride Management Assist (SMA) SystemChange in 6 Minute Walk Test From Baseline in Distance (6MWT)Post Training Assessment1268.24 units on a scaleStandard Deviation 344.0931699
Stride Management Assist (SMA) SystemChange in 6 Minute Walk Test From Baseline in Distance (6MWT)3 Month Post Training Assessment1230.3088 units on a scaleStandard Deviation 375.9471237
Impairment Based TherapyChange in 6 Minute Walk Test From Baseline in Distance (6MWT)3 Month Post Training Assessment1035.1053 units on a scaleStandard Deviation 185.5663909
Impairment Based TherapyChange in 6 Minute Walk Test From Baseline in Distance (6MWT)Pre Training Assessment794.33 units on a scaleStandard Deviation 151.703575
Impairment Based TherapyChange in 6 Minute Walk Test From Baseline in Distance (6MWT)Post Training Assessment1065.5567 units on a scaleStandard Deviation 227.1440369
Impairment Based TherapyChange in 6 Minute Walk Test From Baseline in Distance (6MWT)Mid Treatment Assessment963.1633 units on a scaleStandard Deviation 227.048913
Secondary

Numeric Pain Rating Scale (NPRS)

The NPRS is an 11-point scale from 0-10 where patients verbally select a value that is most in line with the intensity of pain that they have experienced in the last 24 hours from 0 (no pain) to 10 (the most intense pain imaginable).

Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)

Population: One subject dropped out at baseline screening, prior to assignment to any group. One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.

ArmMeasureGroupValue (MEAN)Dispersion
Stride Management Assist (SMA) SystemNumeric Pain Rating Scale (NPRS)Pre Training Assessment0.733336 units on a scaleStandard Deviation 1.589901
Stride Management Assist (SMA) SystemNumeric Pain Rating Scale (NPRS)Mid Training Assessment1.166668 units on a scaleStandard Deviation 1.83081
Stride Management Assist (SMA) SystemNumeric Pain Rating Scale (NPRS)Post Training Assessment0.879996 units on a scaleStandard Deviation 1.83081
Stride Management Assist (SMA) SystemNumeric Pain Rating Scale (NPRS)3 Month Post Training Assessment1.568606 units on a scaleStandard Deviation 2.136855
Impairment Based TherapyNumeric Pain Rating Scale (NPRS)3 Month Post Training Assessment0.587721053 units on a scaleStandard Deviation 1.235250407
Impairment Based TherapyNumeric Pain Rating Scale (NPRS)Pre Training Assessment0.680004 units on a scaleStandard Deviation 1.67631206
Impairment Based TherapyNumeric Pain Rating Scale (NPRS)Post Training Assessment0.599995 units on a scaleStandard Deviation 1.45295656
Impairment Based TherapyNumeric Pain Rating Scale (NPRS)Mid Training Assessment0.72458 units on a scaleStandard Deviation 1.61792765
Secondary

Participants Receiving Transcranial Magnetic Stimulation (TMS)

To compare the effect of training on the connections between the brain and leg muscles (descending corticomotor drive) using a non-invasive brain stimulation called transcranial magnetic stimulation (TMS). TMS is a safe, non-invasive, painless method of brain stimulation that has been widely used to study the physiology of the representations of muscles in the motor cortex in healthy and neurologically disordered individuals13. Very short duration (\< 1 ms) magnetic pulses are applied via an insulated wire coil placed on the intact scalp overlaying the motor cortical area projecting to a target muscle. Each pulse induces a motor evoked potential (MEP) in a target muscle that can be readily monitored by recording Electromyogram (EMG) from that muscle. A figure-of-eight or double cone coil is typically used to deliver focal magnetic pulses to a number of scalp sites over the cortical area representing a muscle of interest.

Time frame: Session 0 (initial visit);Session 20 (between 6-8 weeks)

Population: One subject dropped before being assigned to a group. One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Stride Management Assist (SMA) SystemParticipants Receiving Transcranial Magnetic Stimulation (TMS)Session 015 Participants
Stride Management Assist (SMA) SystemParticipants Receiving Transcranial Magnetic Stimulation (TMS)Session 2015 Participants
Impairment Based TherapyParticipants Receiving Transcranial Magnetic Stimulation (TMS)Session 015 Participants
Impairment Based TherapyParticipants Receiving Transcranial Magnetic Stimulation (TMS)Session 2015 Participants
Secondary

Patient Health Questionnaire-9 (PHQ-9)

PHQ-9 is a 9-item self-report questionnaire designed to diagnose both the presence of depressive symptoms as well as to characterize the severity of depression. A single question rates how difficult problems have made it to do work, take care of things at home or get along with other people using a 4 level scale (not difficult at all to extremely difficult). Each item is scored from 0-3; total scores may be 0-27, with higher scores representing increased severity of depression.

Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)

Population: One subject dropped out at baseline screening, prior to assignment to any group. One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.

ArmMeasureGroupValue (MEAN)Dispersion
Stride Management Assist (SMA) SystemPatient Health Questionnaire-9 (PHQ-9)Pre Training Assessment3.72 units on a scaleStandard Deviation 3.553402
Stride Management Assist (SMA) SystemPatient Health Questionnaire-9 (PHQ-9)Mid Training Assessment2.88 units on a scaleStandard Deviation 2.437895
Stride Management Assist (SMA) SystemPatient Health Questionnaire-9 (PHQ-9)Post Training Assessment2.32 units on a scaleStandard Deviation 2.267891826
Stride Management Assist (SMA) SystemPatient Health Questionnaire-9 (PHQ-9)3 Month Post Training Assessment3.352941 units on a scaleStandard Deviation 2.935583
Impairment Based TherapyPatient Health Questionnaire-9 (PHQ-9)3 Month Post Training Assessment2.631578947 units on a scaleStandard Deviation 2.8908000088
Impairment Based TherapyPatient Health Questionnaire-9 (PHQ-9)Pre Training Assessment3.68 units on a scaleStandard Deviation 4.31779265
Impairment Based TherapyPatient Health Questionnaire-9 (PHQ-9)Post Training Assessment2.16 units on a scaleStandard Deviation 3.15805848
Impairment Based TherapyPatient Health Questionnaire-9 (PHQ-9)Mid Training Assessment3.12 units on a scaleStandard Deviation 4.12633817
Secondary

Stroke Specific Quality of Life Scale (SS-QOL)

A 49 item assessment grouped into 12 domains of health-related quality of life in stroke survivors; including areas of mobility, energy, upper extremity function, work and productivity, mood, self-care, social roles, family roles, vision, language, thinking, personality. Each individual domain consists of 3 to 10 items that are averaged to generate an overall score, each item is rated on a 5- point Likert scale, with a minimum value of 1 (meaning the worst outcome) and a maximum value of 5 (meaning the best outcome). Domains scores (non-weighted average of item scores) and a summary score (non-weighted average of all 12 domain scores) are computed. Summary scores range from 49-245, with higher scores indicating better functioning.

Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)

Population: One subject dropped out at baseline screening, prior to assignment to any group. One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.

ArmMeasureGroupValue (MEAN)Dispersion
Stride Management Assist (SMA) SystemStroke Specific Quality of Life Scale (SS-QOL)Pre Training Assessment198.16 units on a scaleStandard Deviation 21.30665
Stride Management Assist (SMA) SystemStroke Specific Quality of Life Scale (SS-QOL)Mid Training Assessment204.8 units on a scaleStandard Deviation 23.02897
Stride Management Assist (SMA) SystemStroke Specific Quality of Life Scale (SS-QOL)Post Training Assessment205.6 units on a scaleStandard Deviation 24.54248018
Stride Management Assist (SMA) SystemStroke Specific Quality of Life Scale (SS-QOL)3 Month Post Training Assessment200.3529 units on a scaleStandard Deviation 25.22633
Impairment Based TherapyStroke Specific Quality of Life Scale (SS-QOL)3 Month Post Training Assessment211.5789474 units on a scaleStandard Deviation 27.31771055
Impairment Based TherapyStroke Specific Quality of Life Scale (SS-QOL)Pre Training Assessment193.84 units on a scaleStandard Deviation 25.4945746
Impairment Based TherapyStroke Specific Quality of Life Scale (SS-QOL)Post Training Assessment211.72 units on a scaleStandard Deviation 23.3158029
Impairment Based TherapyStroke Specific Quality of Life Scale (SS-QOL)Mid Training Assessment205.36 units on a scaleStandard Deviation 23.5741384
Secondary

The Modified Falls Efficacy Scale (mFES)

14 item questionnaire assessing individuals' confidence in their ability to perform tasks without falling. Individuals rate their confidence from 0 (not confident at all) to 100 (completely confident).

Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)

Population: One subject dropped out at baseline screening, prior to assignment to any group. One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.

ArmMeasureGroupValue (MEAN)Dispersion
Stride Management Assist (SMA) SystemThe Modified Falls Efficacy Scale (mFES)Pre Training Assessment8.3803 units on a scaleStandard Deviation 1.448756
Stride Management Assist (SMA) SystemThe Modified Falls Efficacy Scale (mFES)Mid Training Assessment8.9228 units on a scaleStandard Deviation 1.061062
Stride Management Assist (SMA) SystemThe Modified Falls Efficacy Scale (mFES)Post Training Assessment9.0971 units on a scaleStandard Deviation 0.937882386
Stride Management Assist (SMA) SystemThe Modified Falls Efficacy Scale (mFES)3 Month Post Training Assessment9.2941 units on a scaleStandard Deviation 0.785258
Impairment Based TherapyThe Modified Falls Efficacy Scale (mFES)3 Month Post Training Assessment9.078111111 units on a scaleStandard Deviation 1.094633589
Impairment Based TherapyThe Modified Falls Efficacy Scale (mFES)Pre Training Assessment8.4426 units on a scaleStandard Deviation 1.20545002
Impairment Based TherapyThe Modified Falls Efficacy Scale (mFES)Post Training Assessment9.075176 units on a scaleStandard Deviation 0.9848385
Impairment Based TherapyThe Modified Falls Efficacy Scale (mFES)Mid Training Assessment8.719996 units on a scaleStandard Deviation 0.98649669

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026